GeneDx Securities Class Action Lawsuit
Analysis based on 6 articles · First reported Jun 09, 2026 · Last updated Jul 14, 2026
The lawsuit may negatively impact GeneDx Holdings Corporation's stock price due to potential liability and reputational damage. Investors are reminded of the August 3 deadline to seek lead plaintiff status.
The Gross Law Firm has filed a securities class action lawsuit against GeneDx Holdings Corporation Holdings Corp. (NASDAQ: WGS) on behalf of shareholders who purchased shares between April 16, 2025 and May 4, 2026. The complaint alleges that GeneDx Holdings Corporation made false and misleading statements regarding the acquisition of Fabric Genomics, claiming it would improve financials and create efficiencies, while failing to disclose significant problems with Fabric's viability. As a result, GeneDx Holdings Corporation's stock traded at artificially inflated prices. The deadline for lead plaintiff appointment is August 3, 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard